Postdoctoral Training in Cancer Prevention and Control

癌症防治博士后培训

基本信息

  • 批准号:
    10678913
  • 负责人:
  • 金额:
    $ 37.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-24 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT / PROJECT SUMMARY There is strong evidence linking lifestyle and behavioral risk factors with incidence and survival after a range of cancers. Evidence-based interventions using implementation science approaches can substantially reduce disparities and the population burden of cancer. The number of individuals affected by cancer continues to grow as the U.S. population ages, and disparities in cancer incidence and mortality remain by race/ethnicity, socioeconomic level, and geography. As the NCI Blue Ribbon Research Panel noted, this is a critical time to use implementation science methods and insure that we train investigators in cancer prevention and control research who can reach multiple groups within a population. Increasingly, our health promotion goals cannot be achieved by working within a single discipline. Thus, our ongoing T32 Postdoctoral Training Program in Cancer Prevention and Control aims to bridge this gap. During our first cycle of funding, we have demonstrated success in recruiting, retaining, and training successful researchers, and note that half our trainees come from under-represented minority backgrounds. Trainees also represented multiple home disciplines. Trainees from our first funding cycle have gone on to obtain faculty positions and grant funding, including a K99-R00. We will continue to leverage institutional resources and ongoing NIH-funded research to sustain our training program and enhance the training experience. Our training program includes structured elements such as individual development plans, mentored research experiences, and customizable didactic training opportunities to complement training in implementation science and cancer health disparities. Our innovative training also includes a transdisciplinary journal club, career development programming, and training in communicating with media and lay audiences. Our process of evaluation and adaptation of the training experience based on internal and external advisors and the ever-changing field of cancer prevention and control, have resulted in us adding required training in cancer health disparities and implementation science. Washington University School of Medicine and Siteman Cancer Center offer a rich environment for trainees, and our transdisciplinary training in cancer prevention and control offers a unique resource to the university environment. This T32 mechanism allows us to train PhD and MD scientists to conduct transdisciplinary research and lead the next generation of cancer prevention and control researchers.
摘要/项目总结 有强有力的证据表明,生活方式和行为风险因素与一系列治疗后的发病率和生存率有关。 癌的采用实施科学方法的循证干预措施可以大大减少 差异和癌症的人口负担。受癌症影响的人数继续增加, 随着美国人口老龄化而增长,癌症发病率和死亡率的差异仍然存在于种族/民族之间, 社会经济水平和地理位置。正如NCI蓝带研究小组指出的那样,这是一个 这是使用实施科学方法并确保我们培训癌症预防研究人员的关键时刻 并控制能够接触到人群中多个群体的研究。我们的健康推广 在单一学科内工作是无法实现目标的。因此,我们正在进行的T32博士后 癌症预防和控制培训方案旨在弥补这一差距。在我们的第一轮融资中, 我们在招募、留住和培训成功的研究人员方面取得了成功, 我们的受训人员来自代表性不足的少数族裔背景。学员还代表多个家庭 学科我们第一个资助周期的学员已经获得了教职和赠款, 包括K99-R 00我们将继续利用机构资源和正在进行的NIH资助研究, 继续我们的培训计划,并加强培训经验。我们的培训计划包括: 个人发展计划,指导研究经验和可定制的教学等要素 培训机会,以补充实施科学和癌症健康差距方面的培训。我们 创新培训还包括跨学科期刊俱乐部,职业发展规划, 与媒体和非专业观众沟通的培训。我们的评估和调整过程 基于内部和外部顾问以及不断变化的癌症预防领域的培训经验 和控制,导致我们增加了癌症健康差异和实施方面的必要培训, 科学华盛顿大学医学院和Siteman癌症中心为您提供了丰富的环境, 我们的跨学科培训在癌症预防和控制提供了一个独特的资源, 大学环境。这种T32机制使我们能够培训博士和MD科学家进行 跨学科研究,引领下一代癌症防控研究者。

项目成果

期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Comparative Analysis of Online Medical Record Utilization and Perception by Cancer Survivorship.
  • DOI:
    10.1097/mlr.0000000000001413
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Khan S;Lewis-Thames MW;Han Y;Fuzzell L;Langston ME;Moore JX
  • 通讯作者:
    Moore JX
The adult in the room: The push and pull of parental involvement in research with children.
Sex disparities in COVID-19 outcomes in the United States: Quantifying and contextualizing variation.
  • DOI:
    10.1016/j.socscimed.2022.114716
  • 发表时间:
    2022-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Danielsen AC;Lee KM;Boulicault M;Rushovich T;Gompers A;Tarrant A;Reiches M;Shattuck-Heidorn H;Miratrix LW;Richardson SS
  • 通讯作者:
    Richardson SS
Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.
  • DOI:
    10.1186/s12894-021-00816-5
  • 发表时间:
    2021-03-27
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Khan S;Wolin KY;Pakpahan R;Grubb RL;Colditz GA;Ragard L;Mabie J;Breyer BN;Andriole GL;Sutcliffe S
  • 通讯作者:
    Sutcliffe S
Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
老年评估和衰弱评分预测骨髓瘤死亡率:系统评价和荟萃分析。
  • DOI:
    10.1016/j.clml.2019.04.014
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Salazar,AnaS;Recinos,LuisaM;Mian,HiraS;Stoll,Carolyn;Simon,LauraE;Sekhon,Subhjit;Colditz,GrahamA;Wildes,TanyaM
  • 通讯作者:
    Wildes,TanyaM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GRAHAM A. COLDITZ其他文献

GRAHAM A. COLDITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GRAHAM A. COLDITZ', 18)}}的其他基金

Core C: Biostatistical and Bioinformatics Core
核心 C:生物统计和生物信息学核心
  • 批准号:
    10708578
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Admin-Core-001
管理核心-001
  • 批准号:
    10709107
  • 财政年份:
    2022
  • 资助金额:
    $ 37.05万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10294013
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction
跨骨髓瘤控制连续体的多发性骨髓瘤比较模型:预防、治疗和缩小差异
  • 批准号:
    10491296
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction
跨骨髓瘤控制连续体的多发性骨髓瘤比较模型:预防、治疗和缩小差异
  • 批准号:
    10331128
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
华盛顿大学参与者参与和癌症基因组测序中心 (WU-PE-CGS)
  • 批准号:
    10294012
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
华盛顿大学参与者参与和癌症基因组测序中心 (WU-PE-CGS)
  • 批准号:
    10759096
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
华盛顿大学参与者参与和癌症基因组测序中心 (WU-PE-CGS)
  • 批准号:
    10599739
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Comparative modeling of multiple myeloma across myeloma control continuum: prevention, treatment, and disparity reduction
跨骨髓瘤控制连续体的多发性骨髓瘤的比较模型:预防、治疗和缩小差异
  • 批准号:
    10831693
  • 财政年份:
    2021
  • 资助金额:
    $ 37.05万
  • 项目类别:
Research Program
研究计划
  • 批准号:
    10020383
  • 财政年份:
    2019
  • 资助金额:
    $ 37.05万
  • 项目类别:

相似海外基金

KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
  • 批准号:
    10763054
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
  • 批准号:
    10844859
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
  • 批准号:
    10829054
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
  • 批准号:
    10758129
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE
主题 453:初级保健中预防癌症的完美医疗助手
  • 批准号:
    10931123
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
PIECES – Towards Large-Scale Adaption and Tailored Implementation of Evidence-Based Primary Cancer Prevention Programmes in Europe and Beyond
部分内容 — 致力于在欧洲及其他地区大规模适应和定制实施循证初级癌症预防计划
  • 批准号:
    10079747
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
    EU-Funded
Co-creating a community engagement knowledge translation summit on improving cancer prevention and screening in Canada
共同创建社区参与知识翻译峰会,以改善加拿大的癌症预防和筛查
  • 批准号:
    480839
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
    Miscellaneous Programs
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
  • 批准号:
    10737017
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
使用移动医疗研究交叉性和健康行为:对边缘化人群的概念模型和癌症预防干预措施的影响
  • 批准号:
    10746886
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING
此要求的目的是为国家癌症研究所 (NCI) 的癌症预防部门 (DCP) 提供监管服务和技术支持。
  • 批准号:
    10974513
  • 财政年份:
    2023
  • 资助金额:
    $ 37.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了